Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Biogen
Explore 61 clinical trials worldwide
Search
Showing 1-50 of 61 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Biogen
Clinical Trials (61)
NCT06628687
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
N/A
Recruiting
20 participants
Started: Oct 26, 2026 · Completed: Apr 30, 2035
1 condition
1 sponsor
1 location
NCT07219043
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
PHASE2
Not yet recruiting
81 participants
Started: Nov 17, 2025 · Completed: Feb 10, 2028
1 condition
1 sponsor
0 locations
NCT07133828
A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old
PHASE1
Recruiting
78 participants
Started: Aug 29, 2025 · Completed: Aug 6, 2026
1 condition
1 sponsor
1 location
NCT07027072
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
PHASE2
Recruiting
114 participants
Started: Aug 6, 2025 · Completed: Dec 31, 2027
3 conditions
1 sponsor
8 locations
NCT07009171
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
PHASE2
Recruiting
75 participants
Started: Jul 29, 2025 · Completed: Jun 30, 2027
3 conditions
1 sponsor
3 locations
NCT07077616
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
EARLY_PHASE1
Recruiting
29 participants
Started: Jul 1, 2025 · Completed: Dec 1, 2029
1 condition
2 sponsors
1 location
NCT07047820
A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy
N/A
Recruiting
200 participants
Started: Jun 30, 2025 · Completed: Aug 24, 2026
1 condition
1 sponsor
1 location
NCT06953583
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
PHASE3
Recruiting
255 participants
Started: Jun 9, 2025 · Completed: Nov 22, 2029
1 condition
1 sponsor
27 locations
NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
PHASE3
Recruiting
180 participants
Started: May 22, 2025 · Completed: Mar 29, 2029
1 condition
1 sponsor
4 locations
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
PHASE3
Recruiting
454 participants
Started: May 8, 2025 · Completed: Jun 5, 2029
1 condition
2 sponsors
59 locations
NCT06955897
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
N/A
Recruiting
45 participants
Started: Apr 24, 2025 · Completed: Feb 26, 2027
1 condition
2 sponsors
1 location
NCT06454721
A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults
PHASE1
Active, not recruiting
5 participants
Started: Jan 30, 2025 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT06555419
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
PHASE1
Recruiting
58 participants
Started: Jan 16, 2025 · Completed: May 15, 2026
1 condition
2 sponsors
18 locations
NCT06741657
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
PHASE1
Recruiting
404 participants
Started: Jan 2, 2025 · Completed: Apr 8, 2026
1 condition
1 sponsor
2 locations
NCT06705725
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
PHASE1
Not yet recruiting
38 participants
Started: Dec 26, 2024 · Completed: Feb 22, 2028
1 condition
1 sponsor
0 locations
NCT06623890
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
N/A
Recruiting
300 participants
Started: Dec 12, 2024 · Completed: Oct 1, 2029
1 condition
1 sponsor
14 locations
NCT06685757
A Trial of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR)
PHASE3
Recruiting
120 participants
Started: Dec 3, 2024 · Completed: Jun 1, 2027
1 condition
1 sponsor
48 locations
NCT06602193
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
PHASE2
Recruiting
50 participants
Started: Oct 24, 2024 · Completed: Feb 28, 2028
1 condition
2 sponsors
16 locations
NCT06054893
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
PHASE1
Recruiting
35 participants
Started: Jul 1, 2024 · Completed: Feb 21, 2030
1 condition
1 sponsor
1 location
NCT06461624
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
PHASE1
Recruiting
15 participants
Started: Jul 1, 2024 · Completed: Oct 31, 2027
1 condition
2 sponsors
2 locations
NCT05767736
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
N/A
Active, not recruiting
10,500 participants
Started: Jun 8, 2024 · Completed: Dec 1, 2032
1 condition
1 sponsor
1 location
NCT06437938
The Effects of Dietary Supplements on Glycemic Control, Body Composition and Hepatic Fat Content in People With Prediabetes
NA
Recruiting
50 participants
Started: Apr 25, 2024 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT06053749
An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
N/A
Active, not recruiting
4 participants
Started: Mar 20, 2024 · Completed: Mar 31, 2026
1 condition
4 sponsors
2 locations
NCT05789758
A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
N/A
Recruiting
20 participants
Started: Dec 15, 2023 · Completed: Oct 31, 2033
1 condition
1 sponsor
11 locations
NCT05866419
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
NA
Recruiting
90 participants
Started: Nov 27, 2023 · Completed: Mar 31, 2027
3 conditions
2 sponsors
20 locations
NCT06064929
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
PHASE1/PHASE2
Recruiting
20 participants
Started: Nov 1, 2023 · Completed: Jun 1, 2026
1 condition
1 sponsor
29 locations
NCT05658497
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
N/A
Recruiting
908 participants
Started: Oct 27, 2023 · Completed: Jul 6, 2032
1 condition
1 sponsor
7 locations
NCT06044337
A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
PHASE3
Enrolling by invitation
322 participants
Started: Oct 3, 2023 · Completed: Dec 11, 2029
2 conditions
1 sponsor
72 locations
NCT05798520
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
PHASE2
Recruiting
275 participants
Started: Jul 25, 2023 · Completed: Sep 7, 2027
1 condition
1 sponsor
77 locations
NCT05925049
A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)
N/A
Active, not recruiting
400 participants
Started: Jun 30, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05618379
Adult Spinal Muscular Atrophy (SMA) China Registry
N/A
Active, not recruiting
200 participants
Started: Jan 6, 2023 · Completed: Jun 1, 2028
1 condition
1 sponsor
12 locations
NCT05575011
A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec
PHASE1
Active, not recruiting
62 participants
Started: Oct 10, 2022 · Completed: Nov 14, 2031
2 conditions
1 sponsor
17 locations
NCT05531565
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
PHASE2/PHASE3
Recruiting
474 participants
Started: Sep 13, 2022 · Completed: Dec 14, 2027
2 conditions
1 sponsor
263 locations
NCT06089018
Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
N/A
Active, not recruiting
125 participants
Started: Sep 10, 2022 · Completed: Sep 10, 2024
1 condition
2 sponsors
1 location
NCT05399888
A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
PHASE2
Active, not recruiting
416 participants
Started: Aug 24, 2022 · Completed: Jan 8, 2029
2 conditions
1 sponsor
138 locations
NCT05475691
Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America
N/A
Active, not recruiting
361 participants
Started: Aug 17, 2022 · Completed: Jan 30, 2025
1 condition
2 sponsors
18 locations
NCT06978985
Adult SMA Research and Clinical Hub
N/A
Recruiting
600 participants
Started: Jul 29, 2022 · Completed: Apr 30, 2027
1 condition
5 sponsors
18 locations
NCT05366829
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
PHASE2
Recruiting
35 participants
Started: Jul 25, 2022 · Completed: Jun 1, 2027
2 conditions
3 sponsors
2 locations
NCT05352919
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
PHASE3
Enrolling by invitation
864 participants
Started: Jun 10, 2022 · Completed: Mar 29, 2030
1 condition
1 sponsor
157 locations
NCT05348785
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
PHASE2
Active, not recruiting
650 participants
Started: Apr 19, 2022 · Completed: Mar 9, 2026
1 condition
2 sponsors
113 locations
NCT05067790
A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)
PHASE3
Active, not recruiting
45 participants
Started: Jan 21, 2022 · Completed: Jun 14, 2027
1 condition
1 sponsor
44 locations
NCT05042921
Pediatric Spinal Muscular Atrophy (SMA) China Registry
N/A
Active, not recruiting
600 participants
Started: Nov 18, 2021 · Completed: Sep 2, 2027
1 condition
1 sponsor
25 locations
NCT05688436
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
N/A
Recruiting
1,178 participants
Started: Sep 24, 2021 · Completed: Jan 17, 2031
1 condition
1 sponsor
1 location
NCT04961567
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
PHASE3
Recruiting
540 participants
Started: Jul 16, 2021 · Completed: Mar 16, 2027
1 condition
1 sponsor
179 locations
NCT04870203
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
PHASE3
Recruiting
178 participants
Started: Jul 15, 2021 · Completed: Dec 31, 2026
1 condition
4 sponsors
36 locations
NCT04895241
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
PHASE3
Recruiting
540 participants
Started: May 25, 2021 · Completed: Mar 16, 2027
1 condition
1 sponsor
169 locations
NCT04856982
A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
PHASE3
Active, not recruiting
158 participants
Started: May 17, 2021 · Completed: Aug 7, 2027
1 condition
1 sponsor
29 locations
NCT04729907
A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)
PHASE3
Active, not recruiting
115 participants
Started: Apr 19, 2021 · Completed: Jul 31, 2026
1 condition
1 sponsor
39 locations
NCT04803929
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
EARLY_PHASE1
Recruiting
25 participants
Started: Mar 3, 2021 · Completed: Mar 1, 2026
2 conditions
2 sponsors
1 location
NCT04468659
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
PHASE3
Active, not recruiting
1,400 participants
Started: Jul 14, 2020 · Completed: Jan 16, 2031
2 conditions
4 sponsors
109 locations
«
Previous
1
2
Next